HOME >> BIOLOGY >> NEWS
Rett Syndrome traced to defective gene 'silencer'

caused by defects in other components in this pathway, perhaps autism, for example."

Though the scientists have identified a fraction of the mutations affecting their RTT patients, Zoghbi believes that they will find the other mutations in the DNA sequences of the MECP2 gene that have yet to be analyzed. And while the discovery of the mutations may someday suggest possible therapies for this tragic disorder, the more immediate result should be a test for the early diagnosis and prenatal detection of RTT.


'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
1-Oct-1999


Page: 1 2 3 4

Related biology news :

1. Introduction of the Rett protein in post-mitotic neurons rescues Rett Syndrome in mice
2. Researchers discover novel form of the Rett Syndrome protein
3. Study offers new insight into Rett Syndrome
4. RSRF-funded study leads to breakthrough for Rett Syndrome research
5. The Rett Syndrome Research Foundation commits $1.3 million for 2003 research awards
6. Folic acid may have no immediate impact on Down Syndrome
7. A derivative of the green tea leaf may help with Metabolic Syndrome X, a potentially deadly disorder
8. Researchers find a genetic connection in Sudden Infant Death Syndrome (SIDS)
9. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
10. Scientists create first animal model of Rett Syndrome
11. Gene for DiGeorge Syndrome discovered

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2019)... ... May 31, 2019 , ... ... & Rosati recently invested in BioFactura’s $6M Series B Financing Round. , ... value-added institutional investors who bring significant financial and business resources to bear as ...
(Date:5/31/2019)... ... May 30, 2019 , ... Join Julie ... live webinar on Wednesday, June 19, 2019 at 1pm EDT where she ... teams, data management teams and contract research organizations (CROs) can improve collaboration, auditing, ...
(Date:5/26/2019)... ... May 24, 2019 , ... Zolgensma (Novartis, AveXis), an ... was approved for clinical use in the United States by the Food and Drug ... therapy approved to treat inherited genetic disorders in the United States and the second-ever ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... May 13, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; ...
(Date:5/7/2019)... ... May 06, 2019 , ... ... the growing number of repositories being asked to store cellular products being ... team of contributors who are world leaders, who have shared their expertise in ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... REPROCELL USA Inc. has demonstrated its ability to provide various services and ... to enhance customer satisfaction through the effective implementation of its quality management ...
(Date:5/2/2019)... Calif. (PRWEB) , ... May 02, 2019 , ... ... clinical genetics testing company, will present results documenting discrepancies between U.S. insurer policies ... guidelines for patients at risk for hereditary breast and ovarian cancer (HBOC). ...
Breaking Biology Technology:
Cached News: